製薬R&Dの詳細を解き明かす、PharmaR&D Review 2025レポート

Pharma R&D Review 2025レポートでは、40年の歴史を誇る当社データベースをもとに、世界の医薬品開発パイプラインの詳細をご紹介。 企業別、治療分野別、疾患別、ターゲット別、薬剤タイプ別にトレンドを分析し、製薬R&Dの全体像をご提供します。

このレポートで得られるもの：

  • 医薬品開発の流行り廃り
  • 開発中の22,000以上の薬剤に関する豊富なデータ
  • 業界のトレンドセッターやイノベーターの分析
  • 2025年の戦略を立てるための昨シーズンの教訓
''
Citeline may contact you about relevant products, services and content. To opt-out of these communications or to manage what you receive, please visit our Preference Center.

Your information will be used in accordance with our Privacy notice.

Thank you.




Your download should open in a new window. You can also manually download by clicking the button below.

MEET THE SPEAKERS

Headshot of Ian Lloyd.

IAN LLOYD

Senior Director for Pharmaprojects

For 33 years, Ian has been the chief author of the annual Pharma R&D Review. His data-driven insights and unique perspective are a staple in the pharmaceutical calendar. Our webinar is your opportunity to put your questions directly to Ian, and uncover new insights that could unlock your future strategy.

Headshot of Alexandra Shimmings.

ALEXANDRA SHIMMINGS

Executive Editor, Citeline Commercial

As the head of our European editorial team, Alex has covered breathroughs in R&D across a range of therapeutic areas, including infectious diseases, cardiology and cancer. She frequently interviews key players in the industry, keeping her finger on the pulse of the global pharma R&D landscape.